MedAlliance announced today that it received FDA investigational device exemption (IDE) for its Selution SLR drug-eluting balloon.
Geneva, Switzerland-based MedAlliance designed its Selution SLR (sustained limus release) novel sirolimus-eluting balloon to provide a controlled sustained drug release, similar to a drug-eluting stent.
Get the full story at our sister site, Drug Delivery Business News.